EUDA Health Holdings Limited (EUDA) - Net Assets
Based on the latest financial reports, EUDA Health Holdings Limited (EUDA) has net assets worth $-3.73 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.12 Million) and total liabilities ($5.85 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are EUDA Health Holdings Limited's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.73 Million |
| % of Total Assets | -175.57% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
EUDA Health Holdings Limited - Net Assets Trend (2020–2024)
This chart illustrates how EUDA Health Holdings Limited's net assets have evolved over time, based on quarterly financial data. Also explore EUDA Health Holdings Limited total assets for the complete picture of this company's asset base.
Annual Net Assets for EUDA Health Holdings Limited (2020–2024)
The table below shows the annual net assets of EUDA Health Holdings Limited from 2020 to 2024. For live valuation and market cap data, see market value of EUDA Health Holdings Limited.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-2.57 Million | +65.62% |
| 2023-12-31 | $-7.48 Million | -113.34% |
| 2022-12-31 | $-3.51 Million | -684.46% |
| 2021-12-31 | $600.05K | +289.08% |
| 2020-12-31 | $-317.36K | -- |
Equity Component Analysis
This analysis shows how different components contribute to EUDA Health Holdings Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4941550400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $47.81 Million | % |
| Other Comprehensive Income | $-260.00K | % |
| Total Equity | $-2.55 Million | 100.00% |
EUDA Health Holdings Limited Competitors by Market Cap
The table below lists competitors of EUDA Health Holdings Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cardiex Ltd
AU:CDX
|
$13.23 Million |
|
PT Jaya Bersama Indo Tbk
JK:DUCK
|
$13.23 Million |
|
Aqua Metals Inc
NASDAQ:AQMS
|
$13.23 Million |
|
PAKERS.Co.Ltd
KQ:065690
|
$13.24 Million |
|
Inbest Prime III Inmuebles SOCIMI S.A.
MC:YINB3
|
$13.23 Million |
|
INVO Fertility, Inc.
NASDAQ:IVF
|
$13.23 Million |
|
Origin Agritech Ltd
NASDAQ:SEED
|
$13.22 Million |
|
Indiana Resources Ltd
AU:IDA
|
$13.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EUDA Health Holdings Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -7,498,551 to -2,553,000, a change of 4,945,551.
- Net loss of 15,357,000 reduced equity.
- New share issuances of 50,000 increased equity.
- Other comprehensive income decreased equity by 74,532.
- Other factors increased equity by 20,327,083.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-15.36 Million | -601.53% |
| Share Issuances | $50.00K | +1.96% |
| Other Comprehensive Income | $-74.53K | -2.92% |
| Other Changes | $20.33 Million | +796.2% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares EUDA Health Holdings Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $-0.97 | $15.28 | x |
| 2021-12-31 | $1.13 | $15.28 | x |
| 2022-12-31 | $-5.85 | $15.28 | x |
| 2023-12-31 | $-6.55 | $15.28 | x |
| 2024-12-31 | $-1.57 | $15.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EUDA Health Holdings Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -382.87%
- • Asset Turnover: 2.32x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (33.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | 1.98% | 1.51x | 0.00x | $211.63K |
| 2021 | 165.92% | 18.97% | 0.57x | 15.35x | $812.71K |
| 2022 | 0.00% | -661.06% | 0.15x | 0.00x | $-24.53 Million |
| 2023 | 0.00% | -270.86% | 2.83x | 0.00x | $-9.29 Million |
| 2024 | 0.00% | -382.87% | 2.32x | 0.00x | $-15.10 Million |
Industry Comparison
This section compares EUDA Health Holdings Limited's net assets metrics with peer companies in the Real Estate Services industry.
Industry Context
- Industry: Real Estate Services
- Average net assets among peers: $6,962,097,610
- Average return on equity (ROE) among peers: -177.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EUDA Health Holdings Limited (EUDA) | $-3.73 Million | 0.00% | N/A | $13.23 Million |
| reAlpha Tech Corp. Common Stock (AIRE) | $1.57 Million | -1660.19% | 6.65x | $42.58 Million |
| Avalon GloboCare Corp. (ALBT) | $7.10 Million | -111.27% | 1.95x | $3.37 Million |
| American Realty Investors Inc (ARL) | $816.51 Million | 0.49% | 0.25x | $235.34 Million |
| Altisource Portfolio Solutions SA (ASPS) | $86.35 Million | 30.08% | 0.40x | $76.47 Million |
| Ke Holdings Inc (BEKE) | $66.79 Billion | 4.16% | 0.56x | $18.34 Billion |
| CBRE Group Inc Class A (CBRE) | $784.29 Million | 4.25% | 5.43x | $42.20 Billion |
| Comstock Holding Companies Inc (CHCI) | $6.63 Million | -68.11% | 4.29x | $158.95 Million |
| Compass Inc (COMP) | $-681.60 Million | 0.00% | 0.00x | $5.49 Billion |
| CoStar Group Inc (CSGP) | $359.01 Million | 5.21% | 0.13x | $14.72 Billion |
| Cushman & Wakefield plc (CWK) | $1.45 Billion | 17.26% | 4.45x | $2.99 Billion |
About EUDA Health Holdings Limited
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.